Author Correction: Neoadjuvant atezolizumab for resectable non-small cell lung cancer: an open-label, single-arm phase II trial.

Autor: Chaft JE; Memorial Sloan Kettering Cancer Center, New York, NY, USA.; Weill Cornell Medical College, New York, NY, USA., Oezkan F; The Ohio State University Comprehensive Cancer Center, Columbus, OH, USA.; University Medicine Essen, Ruhrlandklinik, Department of Interventional Pulmonology, University Duisburg-Essen, Essen, Germany.; German Cancer Research Center (DKFZ), A420, Heidelberg, Germany.; Fifth Medical Department, Section of Pulmonology, Faculty of the University of Heidelberg, University Medicine Mannheim, Mannheim, Germany., Kris MG; Memorial Sloan Kettering Cancer Center, New York, NY, USA.; Weill Cornell Medical College, New York, NY, USA., Bunn PA; University of Colorado School of Medicine, Aurora, CO, USA., Wistuba II; The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Kwiatkowski DJ; Dana-Farber Cancer Institute, Boston, MA, USA.; Brigham and Women's Hospital, Boston, MA, USA., Owen DH; The Ohio State University Comprehensive Cancer Center, Columbus, OH, USA.; The Ohio State University Wexner Medical Center, Columbus, OH, USA., Tang Y; Brigham and Women's Hospital, Boston, MA, USA., Johnson BE; Dana-Farber Cancer Institute, Boston, MA, USA.; Brigham and Women's Hospital, Boston, MA, USA., Lee JM; David Geffen School of Medicine at UCLA, Los Angeles, CA, USA., Lozanski G; The Ohio State University Wexner Medical Center, Columbus, OH, USA., Pietrzak M; The Ohio State University Wexner Medical Center, Columbus, OH, USA., Seweryn M; The Ohio State University Wexner Medical Center, Columbus, OH, USA.; Biobank Lab, Department of Molecular Biophysics, University of Lodz, Lodz, Poland.; Centre for Data Analysis, Modeling and Computational Sciences, University of Lodz, Lodz, Poland., Byun WY; The Ohio State University Wexner Medical Center, Columbus, OH, USA., Schulze K; Genentech, Inc., South San Francisco, CA, USA., Nicholas A; Genentech, Inc., South San Francisco, CA, USA., Johnson A; Genentech, Inc., South San Francisco, CA, USA., Grindheim J; Genentech, Inc., South San Francisco, CA, USA., Hilz S; Genentech, Inc., South San Francisco, CA, USA., Shames DS; Genentech, Inc., South San Francisco, CA, USA., Rivard C; University of Colorado School of Medicine, Aurora, CO, USA., Toloza E; Moffitt Cancer Center and Research Institute, Tampa, FL, USA., Haura EB; Moffitt Cancer Center and Research Institute, Tampa, FL, USA., McNamee CJ; Dana-Farber Cancer Institute, Boston, MA, USA.; Brigham and Women's Hospital, Boston, MA, USA., Patterson GA; Washington University School of Medicine, St. Louis, MO, USA., Waqar SN; Washington University School of Medicine, St. Louis, MO, USA., Rusch VW; Memorial Sloan Kettering Cancer Center, New York, NY, USA., Carbone DP; The Ohio State University Comprehensive Cancer Center, Columbus, OH, USA. david.carbone@osumc.edu.; Pelotonia Institute for Immuno-Oncology, Columbus, OH, USA. david.carbone@osumc.edu.
Jazyk: angličtina
Zdroj: Nature medicine [Nat Med] 2024 Jan; Vol. 30 (1), pp. 303.
DOI: 10.1038/s41591-023-02627-7
Databáze: MEDLINE